Optimal Encephalitis/Meningitis Roadmap Via Precise Diagnosis and Treatment
- Conditions
- MeningoencephalitisEncephalitisMeningitisNext-Generation SequencingPolymerase Chain Reaction
- Interventions
- Diagnostic Test: Types of etiological diagnostic methods
- Registration Number
- NCT04946682
- Lead Sponsor
- Wen-hong Zhang
- Brief Summary
Encephalitis and meningitis are serious central nervous system diseases. There is currently a lack of comprehensive and accurate diagnosis and treatment pathways. Therefore, we conducted this multicenter, prospective, and randomized controlled study. It was designed to evaluate the diagnostic performance and its impact on the outcomes of the patients enrolled. As such, we came to the results of the optimal process of diagnosis and treatment strategy of encephalitis/meningeal syndromes with improved effective treatments.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 484
-
Patients with suspected meningitis : the patient has a new fever (>38.5℃), accompanied by ≥1 of the following manifestations:
- Stiff neck
- Change in state of consciousness
- Other signs of meningitis: such as meningeal irritation.
-
Patients with suspected encephalitis: Unexplained changes in the state of consciousness for more than 24 hours (including lethargy, agitation, personality changes, etc.) or accompanied by recent memory impairment, with the following ≥1 manifestations:
- Fever during the course of the disease (≥ 38℃); (oral temperature)
- Convulsions or focal neurological symptoms;
- Increase in the number of cerebrospinal fluid cells (>4*10^6/L);
- Abnormal EEG that meets the manifestations of encephalitis and cannot be attributed to other reasons
- Imaging suggests encephalitis (CT or MRI)
-
Have not received effective anti-infective treatment yet
-
Have an identifiable address and live in the area during treatment.
-
Suspected encephalitis/meningitis patients who are willing to participate in trial treatment and follow-up and can give informed consent (if the subject is illiterate, sign or hearing consent is required).
-
Willing to comply with follow-up research procedures.
- Known breastfeeding or pregnancy
- Failure to comply with treatment or follow-up time;
- The researcher believes that there are any conditions (social or medical) that allow subjects to participate in unsafe;
- Participating in other clinical studies
- Insufficient cerebrospinal fluid or blood samples
- Clinically diagnosed infections, tumors or other neurological diseases
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group of mNGS Types of etiological diagnostic methods - Group of PCR Types of etiological diagnostic methods -
- Primary Outcome Measures
Name Time Method The change Modified Rankin Scale (mRS) at 1 year mRS should be measured at 1 year The Modified Rankin Scale at 1 year Grade Description 0 No symptoms
1. Minor symptoms not interfering with lifestyle
2. Symptoms that lead to some restriction in lifestyle, but do not interfere with the patients' ability to look after themselves
3. Symptoms that restrict lifestyle and prevent totally independent living
4. Symptoms that clearly prevent independent living, although the patient does not need constant care and attention
5. Totally dependent, requiring constant help day and night
- Secondary Outcome Measures
Name Time Method Mortality rate at 1 year Mortality rate at 1 year Mortality rate at 1 year
Trial Locations
- Locations (7)
Wuxi No.5 People's Hospital
🇨🇳Wuxi, Jiangsu, China
People's Hospital of Zhuji, Zhejiang Province
🇨🇳Zhuji, Zhejiang, China
The Second Affiliated Hospital of Soochow University
🇨🇳Suzhou, Jiangsu, China
Shanghai Blue Cross Brain Hospital
🇨🇳Shanghai, Shanghai, China
Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine
🇨🇳Nanjing, Jiangsu, China
The First Affiliated Hospital of Soochow University
🇨🇳Suzhou, Jiangsu, China
Shanghai Sixth People's Hospital
🇨🇳Shanghai, Shanghai, China